Salbutamol Sulfate Tablets (硫酸沙丁胺醇片)硫酸沙丁胺醇片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 地奥集团成都药业股份有限公司Chinese legal name: 地奥集团成都药业股份有限公司
主要成分Active Ingredients
- 主要成分含沙丁胺醇Recorded Chinese composition: 主要成分含沙丁胺醇
药物知识说明
主要成分含沙丁胺醇是一种在国家药监局注册认定的药品。该药品含有主要成分含沙丁胺醇-f5f34b76等成分。
该药品关联的活性成分包括：主要成分含沙丁胺醇。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：地奥集团成都药业股份有限公司Chinese legal name: 地奥集团成都药业股份有限公司。
您可以探索含有相同成分的其他药品：主要成分含沙丁胺醇-f5f34b76成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 硫酸沙丁胺醇片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Manufacturers recorded for this product: 地奥集团成都药业股份有限公司Chinese legal name: 地奥集团成都药业股份有限公司.
Explore other medicines containing the same ingredient: 主要成分含沙丁胺醇 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 硫酸沙丁胺醇片Salbutamol Sulfate Tablets (硫酸沙丁胺醇片)
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 按C13H21NO3计算2mgRecorded Chinese specification: 按C13H21NO3计算2mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 地奥集团成都药业股份有限公司Chinese legal name: 地奥集团成都药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H51021533
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H51021533
Manufacturer
Chinese legal name: 地奥集团成都药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H51021533
生产企业
地奥集团成都药业股份有限公司(国产)
适应症
本品用于缓解支气管哮喘或喘息型支气管炎伴有支气管痉挛的病症。
用法用量
口服，成人每次1-2片，一日3次。
不良反应
1.常见肌肉震颤。|2.亦可见恶心、心率加快或心律失常。|3.偶见有头晕、头昏、头痛、目眩、口舌发干、心烦、高血压、失眠、呕吐、颜面潮红等。
禁忌
对本品其他肾上腺素受体激动剂过敏者禁用。
注意事项
1.本品仅有支气管扩张作用，作用持续时间约4小时，不能过量使用，哮喘症状持续不能缓解者要及时找医师诊治。|2.孕妇禁用，哺乳期妇女慎用。|3.高血压，冠状动脉供血不足，心血管功能不全，糖尿病、甲状腺机能亢进等患者慎用。|4.久用本品易产生耐受性，使药效降低，此时患者对肾上腺素等扩张支气管作用的药物也同样产生耐受性，使支气管痉挛不易缓解，哮喘加重。|5.对本品其他肾上腺素受体激动剂过敏者禁用。|6.一般应用3日后症状仍不见缓解，应向医师或药师咨询。|7.当药品性状发生改变时禁止使用。|8.儿童必须在医师诊治、处方后并在成人的监护下使用。|9.请将此药品放在儿童不能接触的地方。
贮藏
遮光，密闭保存。
规格
按C13H21NO3计算2mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.